Aneurin Bevan University Health Board, Gwent, Wales, UK.
Welsh Renal Clinical Network, Wales, UK.
Perit Dial Int. 2022 Nov;42(6):578-584. doi: 10.1177/08968608211061126. Epub 2022 Jan 24.
Previous evidence suggests home-based dialysis to be more cost-effective than unit-based or hospital-based dialysis. However, previous analyses to quantify the costs of different dialysis modalities have used varied perspectives, different methods, and required assumptions due to lack of available data. The National Institute for Health and Care Excellence reports uncertainty about the differences in costs between home-based and unit-based dialysis. This uncertainty limits the ability of policy makers to make recommendations based on cost effectiveness, which also impacts on the ability of budget holders to model the impact of any service redesign and to understand which therapies deliver better value. The aim of our study was to use a combination of top-down and bottom-up costing methods to determine the direct medical costs of different dialysis modalities in one UK nation (Wales) from the perspective of the National Health Service (NHS).
Detailed hybrid top-down and bottom-up micro-costing methods were applied to estimate the direct medical costs of dialysis modalities across Wales. Micro-costing data was obtained from commissioners of the service and from interviews with renal consultants, nurses, accountants, managers and allied health professionals. Top-down costing information was obtained from the Welsh Renal Clinical Network (who commission renal services across Wales) and the Welsh Ambulance Service Trust.
The annual direct cost per patient for home-based modalities was £16,395 for continuous ambulatory peritoneal dialysis (CAPD), £20,295 for automated peritoneal dialysis (APD) and £23,403 for home-based haemodialysis (HHD). The annual cost per patient for unit-based modalities depended on whether or not patients required ambulance transport. Excluding transport, the cost of dialysis was £19,990 for satellite units run in partnership with independent sector providers and £23,737 for hospital units managed and staffed by the NHS. When ambulance transport was included, the respective costs were £28,931 and £32,678, respectively.
Our study is the most comprehensive analysis of the costs of dialysis undertaken thus far in the United Kingdom and clearly demonstrate that CAPD is less costly than other dialysis modalities. When ambulance transport costs are included, other home therapies (APD and HHD) are also less costly than unit-based dialysis. This detailed analysis of the components that contribute to dialysis costs will help inform future cost-effectiveness studies, inform healthcare policy and drive service redesign.
先前的证据表明,家庭透析比单位透析或医院透析更具成本效益。然而,由于缺乏可用数据,以前分析不同透析方式成本的研究使用了不同的视角、方法和所需的假设。国家卫生与保健卓越研究所报告称,对于家庭透析和单位透析的成本差异存在不确定性。这种不确定性限制了政策制定者基于成本效益做出建议的能力,这也影响了预算负责人对任何服务重新设计的影响建模以及了解哪些治疗方法提供更好价值的能力。我们的研究旨在结合自上而下和自下而上的成本核算方法,从国家医疗服务体系(NHS)的角度确定英国一个国家(威尔士)不同透析方式的直接医疗成本。
详细的混合自上而下和自下而上的微观成本核算方法被应用于估计威尔士各地透析方式的直接医疗成本。微观成本数据来自服务的招标机构以及与肾脏顾问、护士、会计师、经理和相关健康专业人员的访谈。自上而下的成本信息来自威尔士肾脏临床网络(负责威尔士各地肾脏服务的招标机构)和威尔士救护车服务信托。
家庭模式的每位患者的年直接成本为持续非卧床腹膜透析(CAPD)为 16395 英镑,自动化腹膜透析(APD)为 20295 英镑,家庭血液透析(HHD)为 23403 英镑。单位模式的每位患者的年度成本取决于患者是否需要救护车运输。不包括运输费用,卫星单位与独立部门供应商合作运营的透析费用为 19990 英镑,NHS 管理和工作人员运营的医院单位的透析费用为 23737 英镑。当包括救护车运输费用时,相应的费用分别为 28931 英镑和 32678 英镑。
我们的研究是迄今为止在英国进行的最全面的透析成本分析,清楚地表明 CAPD 比其他透析方式成本更低。当包括救护车运输成本时,其他家庭疗法(APD 和 HHD)也比单位透析成本更低。对导致透析成本的各个组成部分的详细分析将有助于为未来的成本效益研究提供信息,为医疗保健政策提供信息,并推动服务重新设计。